Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicatingHelicobacter pylori (original) (raw)
Twice-Daily Standard Dose of Omeprazole Achieves the Necessary Level of Acid Inhibition for Helicobacter pylori Eradication. A Randomized Controlled Trial Using Standard and Double Doses of Omeprazole in Triple Therapy
O. Pieramico
Digestive Diseases and Sciences, 2005
View PDFchevron_right
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: Report of an efficacy study
R. Igetei, Stella Smith
World Journal of Gastroenterology, 2014
View PDFchevron_right
Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori
Aurora Bortoli
Alimentary Pharmacology & Therapeutics, 1997
View PDFchevron_right
Omeprazole and Helicobacter Pylori: temporary suppression rather than true eradication
Duncan Bell
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori
Orhan Sezgin
World journal of gastroenterology : WJG, 2004
View PDFchevron_right
A comparison of 5 or 7 days of rabeprazole triple therapy for eradication of Helicobacter pylori
Murdani Abdullah
Medical Journal of Indonesia, 2010
View PDFchevron_right
Comparison of five different treatment regimens for H. pylori eradication
Gabriel Brasil
JPMA. The Journal of the Pakistan Medical Association, 1999
View PDFchevron_right
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection
Aurora Bortoli
Alimentary Pharmacology and Therapeutics, 1998
View PDFchevron_right
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin
S. D Georgopoulos
Digestive diseases and sciences, 2000
View PDFchevron_right
Quadruple of Bismuth, Pantoprazole, Amoxicillin and Metronidazole for the First-Line Helicobacter Pylori Eradication Therapy
kadir yalçın
Lokman Hekim Health Sciences, 2021
View PDFchevron_right
Eradication of Helicobacter pylori Using One-week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study
Robin Spiller
Helicobacter, 1996
View PDFchevron_right
Eradication of Helicobacter pylori by 7-Day Triple-Therapy Regimens Combining Pantoprazole with Clarithromycin, Metronidazole, or Amoxicillin in Patients with Peptic Ulcer Disease: Results of Two Double-Blind, Randomized Studies
Hala El-zimaity
Helicobacter, 2003
View PDFchevron_right
Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily
Shiu Kum Lam
Alimentary Pharmacology and Therapeutics, 2000
View PDFchevron_right
Randomised controlled trial of ranitidine versus omeprazole in combination with antibiotics for eradication of Helicobacter pylori
Tony Tham
The Ulster medical journal, 1996
View PDFchevron_right
Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in brazilian patients with peptic ulcer
Antonio Laudanna
Revista do Hospital das Clínicas, 2001
View PDFchevron_right
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication
A. Spadaccini
Alimentary Pharmacology and Therapeutics, 1998
View PDFchevron_right
Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori
manuel Pabon
Revista Española de Enfermedades Digestivas, 2009
View PDFchevron_right
Comparison of Three 7-Day Pantoprazole-Based Helicobacter pylori Eradication Regimens in a Mexican Population with High Metronidazole Resistance
Luis Herrera López
Clinical Drug Investigation, 2002
View PDFchevron_right
Effectiveness of two quadruple, tetracycline‐or clarithromycin‐containing, second‐line, Helicobacter pylori eradication therapies
Konstantinos Triantafyllou
View PDFchevron_right
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease
Miroslav Ravic
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection
Alfredo Papa
Alimentary Pharmacology & Therapeutics, 1996
View PDFchevron_right
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population
Mahtab Rahbar
View PDFchevron_right
Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital
Jacobo Dib
Arab Journal of Gastroenterology, 2013
View PDFchevron_right
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection
S. Fossi
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial
Rene Luz
Arquivos de Gastroenterologia, 2005
View PDFchevron_right
A Randomized Controlled Trial: Efficacy and Safety of Azithromycin, Ofloxacin, Bismuth, and Omeprazole Compared With Amoxicillin, Clarithromycin, Bismuth, and Omeprazole as Second-Line Therapy in Patients With Helicobacter pylori Infection
Mohammad Minakari
Helicobacter, 2010
View PDFchevron_right
Efficacy and Tolerability of Three Regimens for Helicobacter pylori Eradication: A Multicentre, Double-Blind, Randomised Clinical Trial
Arturo Fueyo
Clinical Drug Investigation, 2001
View PDFchevron_right
Helicobacter Pylori Treatment with Alternative Drugs: Good and Cheap for Developing Countries Furazolidone-Based Treatment- Omeprazole, Furazolidone and Tetracycline Open-Label Trial in A Developing Country: Why Not?
Ethel Chehter
Gastroenterology & Hepatology: Open Access, 2014
View PDFchevron_right